Search results
Results from the WOW.Com Content Network
Asherman's syndrome (AS) is an acquired uterine condition that occurs when scar tissue forms inside the uterus and/or the cervix. [1] It is characterized by variable scarring inside the uterine cavity, where in many cases the front and back walls of the uterus stick to one another.
Dilation (or dilatation) and curettage (D&C) refers to the dilation (widening or opening) of the cervix and surgical removal of sections and/or layers of the lining of the uterus and or contents of the uterus such as an unwanted fetus (early abortion before 13 weeks), remains of a non-viable fetus, retained placenta after birth or abortion as well as any abnormal tissue which may be in the ...
An important risk factor for placenta accreta is placenta previa in the presence of a uterine scar. Placenta previa is an independent risk factor for placenta accreta. Additional reported risk factors for placenta accreta include maternal age and multiparity, other prior uterine surgery, prior uterine curettage, uterine irradiation, endometrial ablation, Asherman syndrome, uterine leiomyomata ...
Asherman has published dozens of medical articles. Among other things, he described a syndrome that bears his name, Asherman's Syndrome, which includes scarring and infection in the uterus due to curettage, which was first described by a German doctor ( Heinrich Fritsch ) in 1894 but was characterized following two articles by Asherman in 1948 ...
Hysteroscopy has the benefit of allowing direct visualization of the uterus, thereby avoiding or reducing iatrogenic trauma to delicate reproductive tissue which may result in Asherman's syndrome. Hysteroscopy allows access to the uterotubal junction for entry into the fallopian tube ; this is useful for tubal occlusion procedures for ...
Single-use double-valve manual vacuum aspirator. Vacuum or suction aspiration is a procedure that uses a vacuum source to remove an embryo or fetus through the cervix.The procedure is performed to induce abortion, as a treatment for incomplete spontaneous abortion (otherwise commonly known as miscarriage) or retained fetal and placental tissue, or to obtain a sample of uterine lining ...
Dr. A. Thomas McLellan, the co-founder of the Treatment Research Institute, echoed that point. “Here’s the problem,” he said. Treatment methods were determined “before anybody really understood the science of addiction. We started off with the wrong model.” For families, the result can be frustrating and an expensive failure.
The treatment choices of those referred to hospital in the UK for heavy menstrual bleeding. [20] The first line treatment option for those with HMB and no identified pathology, fibroids less than 3 cm in diameter, and/or suspected or confirmed adenomyosis is the levonorgestrel-releasing intrauterine system (LNG-IUS). [15]